IDEXX Laboratories, US45168D1046

SNAP 4Dx Plus Test from IDEXX Laboratories - quick tick-borne screening in minutes

23.06.2026 - 03:22:01 | ad-hoc-news.de

The SNAP 4Dx Plus Test screens dogs for heartworm and three common tick-borne diseases in just a few minutes right at the vet clinic. This bestseller drives the price of IDEXX Laboratories shares (ISIN US45168D1046).

IDEXX Laboratories, US45168D1046
IDEXX Laboratories, US45168D1046

Reviewed: ad hoc news New Release & Launch desk. Edited and checked on 2026-06-23, 03:16. Details in the imprint.

SNAP 4Dx Plus Test from IDEXX Laboratories sits on the exam table like a small white cassette while a nervous beagle sniffs at it and taps his nails on the steel surface. A few drops of blood, a click on the activator, then the color spots slowly appear.

What SNAP 4Dx Plus checks

The SNAP 4Dx Plus Test is a rapid in-clinic immunoassay that screens dogs for heartworm disease and three widespread tick-borne infections in a single run. According to veterinary explanations, the panel covers antigens for heartworm and antibodies for Lyme disease, Ehrlichia and Anaplasma.

Each disposable test housing contains pre-loaded reagents and a built-in activation mechanism so veterinary nurses handle only the blood sample and a buffered conjugate. The visual readout appears as clear blue spots on the membrane, which many clinicians can distinguish at a glance even in a busy treatment room.

How it fits into a busy clinic

For a vet like IDEXX customer Dr. Sarah Martinez, the appeal is speed and workflow. She can draw blood during the consultation, start the SNAP 4Dx Plus Test in the treatment area, and walk back into the exam room with results less than ten minutes later, keeping the conversation with the dog owner continuous.

The cassette has a tactile snap lever that gives a clear click when it is activated, which helps nurses avoid half-engaged runs during hectic morning rushes. Once activated, the sample and conjugate flow through without further handling, reducing the chance of pipetting errors.

Go deeper

Background on IDEXX Laboratories shares

Rapid in-house tests like SNAP 4Dx Plus feed IDEXX Laboratories recurring revenue and are a key pillar of its diagnostics growth story for investors.

Where the test helps most

SNAP 4Dx Plus is designed for regions where heartworm and ticks are endemic and where dogs visit the vet routinely for annual wellness checks. In those markets, the test acts as a screening baseline before starting or adjusting parasite prevention plans, which aligns with IDEXX CEO Jay Mazelsky's focus on preventive care services.

Because the cassette combines four targets into one run, clinics can avoid multiple separate tests that would require more blood, more hands-on time and more storage space in the lab fridge. That bundled approach supports consistent annual screening even in small practices with limited bench area.

Limitations and interpretation

Like other rapid immunoassays, the SNAP 4Dx Plus Test is a screening tool, not a full diagnostic workup. Veterinarians are expected to confirm positive results for heartworm and tick-borne disease with follow-up lab tests or imaging before committing to long treatment regimens.

False negatives can occur in very early infections or when a dog has been on some forms of preventive medication, so IDEXX emphasizes annual repeat testing and risk-based interpretation rather than treating a single result as the last word.

Stock angle and market role

All told, SNAP 4Dx Plus sits at the heart of IDEXX Laboratories recurring diagnostics revenue, anchoring a much wider portfolio of analyzers and reference lab services that expand the data around each patient visit. IDEXX Laboratories shares are listed on Nasdaq in New York under the ticker IDXX, and the company highlights the growth of its Companion Animal Group diagnostics line as a core driver in its investor presentations.

Key facts on SNAP 4Dx Plus

  • Product: SNAP 4Dx Plus Test
  • Manufacturer: IDEXX Laboratories, Inc.
  • Category: New release/launch - rapid veterinary diagnostic test
  • Launch: Existing product, positioned for annual wellness screening in current portfolios
  • RRP / Price: Sold via veterinary distribution channels, pricing varies by region and contract
  • Availability: Primarily through veterinary clinics and distributors in North America and other companion-animal markets
  • Target group: Veterinarians and veterinary nurses treating dogs at risk of heartworm and tick-borne disease
  • Highlight / USP: Four-disease screening (heartworm, Lyme, Ehrlichia, Anaplasma) in a single rapid in-clinic cassette

Find more impressions and experiences

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.

en | US45168D1046 | IDEXX LABORATORIES | boerse | 69607076 | bgmi